Active Not RecruitingNCT04951700
This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
- Condition
- Schizophrenia
Active Not RecruitingNCT06360562
This study is looking at care and outcomes for people with anxiety or psychosis. Taking part may give some people access to Resilience Training, but direct benefit is not guaranteed.
AnxietyOtherOver 14 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Anxiety
RecruitingNCT05929352
This study is looking at whether a digital support tool can help people with Schizophrenia. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT05440214
This study is looking at whether Dialectical Behavior Therapy Skills Training can help people with Psychosis or Suicide. Participants take part in Dialectical Behavior Therapy Skills Training and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
RecruitingNCT02916810
This study is looking at care and outcomes for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
RecruitingNCT05617898
This study is looking at whether Motivational Interviewing can help people with Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- University of Alabama at Birmingham
- Condition
- Schizophrenia
RecruitingNCT06194344
This study is looking at whether Individualized imagery can help people with Psychosis. Participants take part in Individualized imagery and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
RecruitingNCT06058702
This study is comparing Delta-9-THC Very Low Dose with placebo for people with Schizophrenia or Cannabis Use Disorder. Participants receive Delta-9-THC Very Low Dose or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 21 Years to 60 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
Active Not RecruitingNCT02102113
This study is comparing Placebo with placebo for people with psychosis. Participants receive Placebo or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
Active Not RecruitingNCT02407808
This study is looking at care and outcomes for people with Cannabis or psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT06961916
This study is looking at whether Active rTMS can help people with Schizophrenia. Participants take part in Active rTMS and complete follow-up assessments.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center, Houston
- Condition
- Schizophrenia
RecruitingNCT04366518
This study is comparing Rivastigmine Transdermal System with placebo for people with Hallucinations, Auditory or Psychosis. Participants receive Rivastigmine Transdermal System or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT03781115
This study is comparing Ziprasidone with placebo for people with Schizophrenia. Participants receive Ziprasidone or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- University of Arizona
- Condition
- Schizophrenia
RecruitingNCT06126224
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Belgium, Canada, Chile, China, Greece, Hungary, Mexico, Peru, Poland, South Korea, Switzerland, Turkey, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
Enrolling By InvitationNCT07095465
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Taking part may give some people access to ACP-204, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 84 Years
- Countries
- Czech Republic, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT05980949
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czech Republic, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Mexico, Peru, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine, United Kingdom
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT07029581
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 84 Years
- Countries
- Bulgaria, Czech Republic, France, Italy, Serbia, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
RecruitingNCT05511363
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Bulgaria, Croatia, Czech Republic, France, Germany, Italy, Serbia, Slovakia, Spain, United Kingdom, United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
RecruitingNCT07226895
This study is comparing MT1988 Low Dose with placebo for people with Clinical High Risk for Psychosis. Participants receive MT1988 Low Dose or placebo and complete study visits and assessments.
SchizophreniaOtherFrom 17 Years to 30 Years
- Countries
- United States
- Sponsor
- Monument Therapeutics Limited
- Condition
- Schizophrenia
RecruitingNCT06159673
This observational study is following people with Alzheimer's Disease Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
SchizophreniaOtherFrom 55 Years to 95 Years
- Countries
- Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
Active Not RecruitingNCT05310838
This study is looking at whether Behavioral Activation for First Episode Psychosis can help people with Engagement or First Episode Psychosis. Participants receive Behavioral Activation for First Episode Psychosis or usual care and complete study visits and assessments.
SchizophreniaOtherFrom 15 Years to 35 Years
- Countries
- United States
- Sponsor
- California State University, San Bernardino
- Condition
- Schizophrenia
Enrolling By InvitationNCT06139874
This study is looking at whether THRIVE can help people with Childhood Mental Disorder. Participants take part in THRIVE and complete follow-up assessments.
Mental healthOtherFrom 3 Years to 7 Years
- Countries
- United States
- Sponsor
- Washington University School of Medicine
- Condition
- Mental health
Active Not RecruitingNCT05554094
This study is looking at whether a digital support tool can help people with Ptsd, Stress Disorders, Traumatic, Stress Disorders, Post-Traumatic, or Trauma and Stressor Related Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
Mental healthOtherFrom 21 Years to 64 Years
- Countries
- United States
- Sponsor
- Ohio State University
- Condition
- Mental health
Enrolling By InvitationNCT06194799
This study is looking at care and outcomes for people with Alzheimer's Disease Psychosis. Taking part may give some people access to ACP-204, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 55 Years to 95 Years
- Countries
- Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, United States
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
Active Not RecruitingNCT05967195
This study is looking at whether Financial Incentive and Text-Messages can help people with First-Episode Psychosis. Participants take part in Financial Incentive and Text-Messages and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Pennsylvania
- Condition
- Schizophrenia